Inventor · disambiguated record
In Hwan Bae
Also filed as: BAE IN HWAN
14 granted patents·3 pending applications·27 citations·filing 2011–2022
88Inventor score
Top patents by PatentIndex Score
17 records- 0193US11292786B2Pyrimidine compounds and pharmaceutical compositions for preventing or treating cancers including the sameHANMI PHARM IND CO LTD·Filed 2020·Granted Apr 5, 2022·4 cites·7 claims
- 0287US10280154B2Pyrimidine compound and pharmaceutical use thereofHANMI PHARM IND CO LTD·Filed 2018·Granted May 7, 2019·4 cites·18 claims
- 0385US10519141B2Pyrimidine compound and pharmaceutical use thereofHANMI PHARM IND CO LTD·Filed 2018·Granted Dec 31, 2019·3 cites·11 claims
- 0484US10870639B2Pyrimidine compounds and pharmaceutical compositions for preventing or treating cancers including the sameHANMI PHARM IND CO LTD·Filed 2019·Granted Dec 22, 2020·3 cites·6 claims
- 0579US9388165B2Isoquinoline-5-carboxamide derivative having inhibitory activity for protein kinaseHANMI PHARM IND CO LTD·Filed 2013·Granted Jul 12, 2016·6 cites·13 claims
- 0676US12325698B2Pyrimidine compounds and pharmaceutical compositions for preventing or treating cancers including the sameHANMI PHARMACEUTICAL CO LTD·Filed 2022·Granted Jun 10, 2025·0 cites·8 claims
- 0774US9156852B2Thieno[3,2-D]pyrimidine derivatives having inhibitory activity for protein kinasesHANMI PHARM IND CO LTD·Filed 2012·Granted Oct 13, 2015·3 cites·14 claims
- 0867USRE47451EThieno[3,2-D]pyrimidine derivatives having inhibitory activity for protein kinasesHANMI PHARM IND CO LTD·Filed 2012·Granted Jun 25, 2019·1 cites·63 claims
- 0967US2023060973A1Thieno[3,2-d]pyrimidine derivative compound having inhibitory activity for protein kinaseHANMI PHARM IND CO LTD·Filed 2022·Application pending·0 cites
- 1065US8835458B2Quinoline or quinazoline derivatives with apoptosis inducing activity on cellsBAE IN HWAN·Filed 2011·Granted Sep 16, 2014·3 cites·14 claims
- 1164US11492357B2Thieno[3,2-d]pyrimidine derivative compound having inhibitory activity for protein kinaseHANMI PHARM IND CO LTD·Filed 2018·Granted Nov 8, 2022·0 cites·9 claims
- 1255US2024067613A1Novel quinazoline derivatives as sos1 inhibitors and use thereofHANMI PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 1350US12350265B2Pharmaceutical composition for treating acute myeloid leukemia, containing FLT3 inhibitor and chemotherapeutic agentsHANMI PHARMACEUTICAL CO LTD·Filed 2020·Granted Jul 8, 2025·0 cites·21 claims
- 1449US2024239895A1Combination therapy with a raf inhibitor and a pd-1 axis inhibitorGENENTECH INC·Filed 2022·Application pending·0 cites
- 1548US12433867B2Pharmaceutical composition comprising FLT3 inhibitor and hypomethylating agent for treating acute myeloid leukemiaHANMI PHARMACEUTICAL CO LTD·Filed 2020·Granted Oct 7, 2025·0 cites·11 claims
- 1647US12479845B2Imidazopyridine derivative compounds and use of sameHANMI PHARMACEUTICAL CO LTD·Filed 2020·Granted Nov 25, 2025·0 cites·11 claims
- 1746US11254676B2Pyrazole derivative compound and use thereofHANMI PHARM IND CO LTD·Filed 2018·Granted Feb 22, 2022·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when In Hwan Bae files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →